EFSA sets safe intake level for Delta-8 THC in food across the EU

Published: 19-Nov-2025
Regulatory

EFSA has determined a safe intake level for delta-8 THC, concluding it has similar potency to delta-9 THC and should share the same ARfD. The findings will guide EU discussions on potential regulatory measures

EFSA analysed available data on delta-8 tetrahydrocannabinol (also known as delta-8 THC) in food and set a safe intake level.

Delta-8 THC is a psychoactive cannabinoid occasionally detected in products from the hemp plant Cannabis sativa, such as hemp leaves, seeds and oil.

It is also detected in food products such as candies and supplements marketed as hemp products.  

Consuming delta-8 THC impacts cognitive and psychomotor abilities and similarly increases heart rate to delta-9 THC, the main chemical responsible for the psychoactive effects of cannabis. 

Considering the similarity in the effects and modes of action between delta-8 THC and delta-9 THC, EFSA scientists established that both chemicals have similar potency.

They concluded that the acute reference dose (ARfD) set in 2015 for delta-9 THC should apply to the total amount of delta-8 THC and delta-9 THC consumed together.

The ARfD is 1 microgram (1 millionth of a gram) per kilogram of body weight per day. 

Based on EFSA’s work, the European Commission and Member States will consider whether regulatory measures are needed for delta-8 THC in food to protect consumers from potential health risks. 

EFSA scientists also recommended that recent studies on delta-9 THC should be considered to re-evaluate its safety. 

  • Companies:
  • EFSA
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

EU regulators focus on nutrient bioavailability and safety in novel micronutrient guideline draft

Read more
NBR spoke with Silvia Valtueña Martinez, Nutrition expert at the EFSA to find out more about the guidelines and how they could impact the nutraceutical and functional food industries

Trending Articles

  1. Ashwagandha: is the UK headed for a ban? The UK’s food safety authority has issued a call for evidence as it mulls risk management options
  2. Kensing secures exclusive EFSA approval for sunflower phytosterols The new approval for Sunvasterol under EFSA’s Novel Food application process grants Kensing commercial exclusivity in Europe, offering food formulators and dietary supplement brands a clean-label and sustainably sourced alternative to traditional soy, rapeseed and pine-based sterols
  3. SEPITONE™ : the new secret to youthful radiance Seppic demonstrated the effectiveness and dual action of its fermented wild bilberry extract on skin aging and complexion in two clinical studies
  4. Biotech veteran Jane Hollingsworth joins Phylloceuticals board Appointment strengthens leadership as company advances plant-based therapeutics
  5. Lonza introduces first USDA organic certified capsule made in North America New Organicaps capsule helps brands meet rising consumer demand for organic supplements

Upcoming event

FI Europe

2–4 December 2025 | Exhibition | Paris, France See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

EU regulators focus on nutrient bioavailability and safety in novel micronutrient guideline draft

NBR spoke with Silvia Valtueña Martinez, Nutrition expert at the EFSA to find out more about the guidelines and how they could impact the nutraceutical and functional food industries
Regulatory

Saccharin no longer considered a cancer risk by the EFSA

EFSA's experts have concluded that saccharin doesn't cause DNA damage as previously believed and is safe for human consumption, though CarobWay's Udi Alroy believes this won't stop the growth of natural sweeteners
Ingredients

Arla Foods receives regulatory nod from EU

This came before the European Food Safety Agency (EFSA) published an opinion that Peptigen IF-3080 ­was safe and suitable
Ingredients

EFSA acknowledges potential of GOS in FSMP applications

The opinion, ‘Safety of the extension of use of galactooligosaccharides (GOS) as a novel food in food for special medical purposes pursuant to Regulation (EU) 2015/2283’, was published on 30 March 2022
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

From hype to hard data: the growing maturity of clinical trials in the nutraceutical industry

The nutraceutical industry is slowly shifting from anecdote to evidence, but persistent regulatory, methodological and standardisation issues continue to hamper the credibility and scalability of clinical research
Manufacturing

Nutra keynote 2025: solve your biggest nutraceutical challenges

From formulation defects to regulatory hurdles, the Nutra Keynote 2025 offers practical solutions to your toughest challenges. Register now and turn obstacles into opportunities
Regulatory

Kensing secures exclusive EFSA approval for sunflower phytosterols

The new approval for Sunvasterol under EFSA’s Novel Food application process grants Kensing commercial exclusivity in Europe, offering food formulators and dietary supplement brands a clean-label and sustainably sourced alternative to traditional soy, rapeseed and pine-based sterols
Subscribe now